Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials-Reference-Cited by-同舟云学术

Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials

Published:2022-05 Issue:3 Volume:16 Page:286-297
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Laufs Ulrich^ORCID,Ballantyne Christie M,Banach Maciej^ORCID,Bays Harold^ORCID,Catapano Alberico L.^ORCID,Duell P. Barton^ORCID,Goldberg Anne C.,Gotto Antonio M.,Leiter Lawrence A.,Ray Kausik K.^ORCID,Bloedon LeAnne T.,MacDougall Diane,Zhang Yang,Mancini G. B. John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference39 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;Circulation,2019

2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

3. Statin intolerance - an attempt at a unified definition. Position paper from an international lipid expert panel;Banach;Arch Med Sci,2015

4. Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users;Cohen;J Clin Lipidol,2012

5. Development and validation of algorithms to identify statin intolerance in a US administrative database;Schulman;Value Health,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table;Journal of Clinical Lipidology;2024-07

2. Effects of statins beyond lipid-lowering agents in ART-treated HIV infection;Frontiers in Immunology;2024-04-09

3. Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies;Annals of Medicine & Surgery;2024-03-12

4. Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023;Atherosclerosis Plus;2024-03

5. Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management;Journal of Clinical Medicine;2024-02-22